139 related articles for article (PubMed ID: 2152777)
21. A controlled, randomized, double-blind trial to evaluate the effect of a supplement of cocoa husk that is rich in dietary fiber on colonic transit in constipated pediatric patients.
Castillejo G; Bulló M; Anguera A; Escribano J; Salas-Salvadó J
Pediatrics; 2006 Sep; 118(3):e641-8. PubMed ID: 16950955
[TBL] [Abstract][Full Text] [Related]
22. Colonic myoelectric activity in the irritable bowel syndrome.
Snape WJ; Carlson GM; Cohen S
Gastroenterology; 1976 Mar; 70(3):326-30. PubMed ID: 765183
[TBL] [Abstract][Full Text] [Related]
23. Effect of bile acid perfusion on colonic motor function in patients with the irritable colon syndrome.
Taylor I; Basu P; Hammond P; Darby C; Flynn M
Gut; 1980 Oct; 21(10):843-7. PubMed ID: 7439803
[TBL] [Abstract][Full Text] [Related]
24. Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study.
Lucey MR; Clark ML; Lowndes J; Dawson AM
Gut; 1987 Feb; 28(2):221-5. PubMed ID: 3030904
[TBL] [Abstract][Full Text] [Related]
25. Colonic sensitive-motor alterations in the irritable bowel syndrome.
Tomas-Ridocci M; Moreno-Osset E; Minguez M; Ballester J; Mora F; Benages A
Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):48-52. PubMed ID: 1756283
[TBL] [Abstract][Full Text] [Related]
26. [Motility of the sigmoid in irritable bowel syndrome and colonic diverticulosis].
Ritsema GH; Thijn CJ; Smout AJ
Ned Tijdschr Geneeskd; 1990 Jul; 134(29):1398-401. PubMed ID: 2374631
[TBL] [Abstract][Full Text] [Related]
27. Effects of desipramine on irritable bowel syndrome compared with atropine and placebo.
Greenbaum DS; Mayle JE; Vanegeren LE; Jerome JA; Mayor JW; Greenbaum RB; Matson RW; Stein GE; Dean HA; Halvorsen NA
Dig Dis Sci; 1987 Mar; 32(3):257-66. PubMed ID: 3545719
[TBL] [Abstract][Full Text] [Related]
28. Effect of stress, meal and neostigmine on rectosigmoid electrical control activity (ECA) in normals and in irritable bowel syndrome patients.
Sarna S; Latimer P; Campbell D; Waterfall WE
Dig Dis Sci; 1982 Jul; 27(7):582-91. PubMed ID: 7083996
[TBL] [Abstract][Full Text] [Related]
29. Effect of tegaserod on recto-sigmoid tonic and phasic activity in constipation-predominant irritable bowel syndrome.
Di Stefano M; Miceli E; Mazzocchi S; Tana P; Missanelli A; Corazza GR
Am J Gastroenterol; 2007 Aug; 102(8):1720-6. PubMed ID: 17521397
[TBL] [Abstract][Full Text] [Related]
30. Wheat fibre and irritable bowel syndrome. A controlled trial.
Manning AP; Heaton KW; Harvey RF
Lancet; 1977 Aug; 2(8035):417-8. PubMed ID: 70639
[TBL] [Abstract][Full Text] [Related]
31. Effect of hyperventilation on distal colonic motility and rectal sensitivity in irritable bowel syndrome.
Maxton DG; Prior A; Whorwell PJ
Digestion; 1991; 48(2):70-4. PubMed ID: 1868972
[TBL] [Abstract][Full Text] [Related]
32. Irritable bowel patients and their long-term response to a high fiber diet.
Hillman LC; Stace NH; Pomare EW
Am J Gastroenterol; 1984 Jan; 79(1):1-7. PubMed ID: 6318552
[TBL] [Abstract][Full Text] [Related]
33. [Clinical symptoms, psychopathology and intestinal motility in patients with "irritable bowel"].
Enck P; Holtkötter B; Whitehead WE; Schuster MM; Weinbeck M
Gastroenterol J; 1990; 50(3):154. PubMed ID: 2288658
[No Abstract] [Full Text] [Related]
34. Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome.
Bijkerk CJ; Muris JW; Knottnerus JA; Hoes AW; de Wit NJ
Aliment Pharmacol Ther; 2004 Feb; 19(3):245-51. PubMed ID: 14984370
[TBL] [Abstract][Full Text] [Related]
35. Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms.
Hebden JM; Blackshaw E; D'Amato M; Perkins AC; Spiller RC
Am J Gastroenterol; 2002 Sep; 97(9):2315-20. PubMed ID: 12358250
[TBL] [Abstract][Full Text] [Related]
36. Role of ispaghula husk in the management of irritable bowel syndrome (a randomized double-blind crossover study).
Golechha AC; Chadda VS; Chadda S; Sharma SK; Mishra SN
J Assoc Physicians India; 1982 Jun; 30(6):353-5. PubMed ID: 6302072
[No Abstract] [Full Text] [Related]
37. [Colonic response to the meal of the right colon, the left colon, the rectosigmoid and the rectosigmoidal junction in digestive functional disorders].
Dapoigny M; Trolese JF; Bommelaer G; Tournut R
Gastroenterol Clin Biol; 1988 Apr; 12(4):361-7. PubMed ID: 3384255
[TBL] [Abstract][Full Text] [Related]
38. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study.
Steadman CJ; Talley NJ; Phillips SF; Zinsmeister AR
Mayo Clin Proc; 1992 Aug; 67(8):732-8. PubMed ID: 1434911
[TBL] [Abstract][Full Text] [Related]
39. The effect of secoverine hydrochloride on stimulated sigmoid motility: a double-blind, placebo controlled cross-over study in irritable bowel syndrome.
Ehsanullah M; Lee DA; Williams T; Pollard P; Gazzard B
Br J Clin Pharmacol; 1985 Mar; 19(3):301-5. PubMed ID: 3986085
[TBL] [Abstract][Full Text] [Related]
40. Chronic severe constipation. Prospective motility studies in 25 consecutive patients.
Reynolds JC; Ouyang A; Lee CA; Baker L; Sunshine AG; Cohen S
Gastroenterology; 1987 Feb; 92(2):414-20. PubMed ID: 3792778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]